Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinnarizine versus topiramate for vestibular migraine
PACTR201909600414183Phase 2Completed
- Sponsor
- Faculty of Medicine, Menoufia University
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of cinnarizine and topiramate in vestibular migraine (VM) (2 arms), sponsored by Faculty of Medicine, Menoufia University. Primary endpoints: Change in monthly frequency of vertigo attacks, Change in monthly frequency of migraine attacks and 1 more. Started Jan 2018; status: completed.
02
Drugs
cinnarizinetopiramate
03
Conditions
vestibular migraine (VM)
Beyond the preview
Go deeper on PACTR201909600414183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201909600414183.